ACTRN12623000172606尚未招募4 期
The efficacy of Low Dose Naltrexone in Fibromyalgia - A randomised controlled cross-over trial
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •a)at least 18 years old;
- •b)diagnosis of FMS according to ACR 2011 criteria by a pain specialist or rheumatologist
- •c)oral morphine equivalent daily dose (OMEDD) less than 60mg;
- •d)provision of written informed consent;
- •e)able to complete questionnaires.
排除标准
- •f)current treatment with naltrexone;
- •g)severe medical or psychiatric illness likely to limit life or participation in trial;
- •h)pregnant or planning pregnancy during study period;
- •i)known allergy to naltrexone or naloxone;
- •j)currently participating in other clinical trials.
研究者
相似试验
尚未招募
1 期
low dose naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long coronavirus disease (long COVID) symptomsMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Long COVIDOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)Infection - Other infectious diseasesNeurological - Other neurological disordersRespiratory - Other respiratory disorders / diseasesACTRN12624001162505Griffith University56
已完成
不适用
Effects of Low Dose Naltrexone in FibromyalgiaPersian Gulf SyndromeFibromyalgiaNCT00568555Stanford University53
进行中（未招募）
1 期
Fibromyalgia and Naltrexone: The FINAL studyMedDRA version: 20.0Level: PTClassification code 10048439Term: FibromyalgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersFibromyalgiaEUCTR2019-000702-30-DKOdense University Hospital99
已完成
2 期
Fibromyalgia and Naltrexone: The FINAL StudyFibromyalgiaNCT04270877Odense University Hospital99
招募中
1 期
ow Dose Naltrexone for the treatment of long COVID-19long COVIDPost COVID-19 ConditionPost-acute sequelae of COVID-19Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12623001042639Griffith University56